Showing 1,601 - 1,620 results of 5,876 for search '"Medication"', query time: 0.07s Refine Results
  1. 1601
  2. 1602

    A mosquito Culex (Melanoconion) iolambdis Dyar (Insecta: Diptera: Culicidae) by Stephanie K. Larrick, Erik M. Blosser, C. Roxanne Connelly

    Published 2010-09-01
    “…It describes this small, dark brown mosquito that exists in the tropics and subtropics and about which little is known — distribution, description, biology, medical importance, and management. Includes references. …”
    Get full text
    Article
  3. 1603

    A Case Report of Gastric Diverticulum-An Uncommon Cause of Dyspepsia by Muhamad Amzar, Ikhwan Sani Mohamad, Syed Hassan Syed Aziz, Wan Mokhzani Wan Mokhter, Siti Rahmah Hashim Isa Merican

    Published 2025-01-01
    “…The diagnosis was made based on medical history and an outpatient Oesophagogastroduodenoscopy (OGDS). …”
    Get full text
    Article
  4. 1604

    Australian Cockroach Periplaneta australasiae Fabricius (Insecta: Blattodea: Blattidae) by Shiyao Jiang, Phillip E. Kaufman

    Published 2015-06-01
    “…This 4-page fact sheet covers the Australian cockroach’s distribution and habitat, biology, medical risks to humans, and management as a pest. …”
    Get full text
    Article
  5. 1605

    A Peculiar Tracheoesophageal Fistula Caused by a Plastic Foreign Body by Chao Chen, Dingyuan Dai, Yu Guo, Chen Sun, Qi Li

    Published 2025-01-01
    “…This paper presents a unique case admitted to the Children’s Hospital of Nanjing Medical University on August 9, 2022, where a plastic fragment resembling a doll’s eye was identified as the precipitating factor. …”
    Get full text
    Article
  6. 1606

    Wheel Bug, Arilus cristatus (Linnaeus) (Insecta: Hemiptera: Reduviidae) by Frank W. Mead

    Published 2017-03-01
    “… Contents: Introduction - Synonymy - Distribution - Description and Identification - Life History - Notes on Behavior - Importance as a Predator - Medical Importance - Enemies - Selected References This document is EENY086, one of a series of the Department of Entomology and Nematology, UF/IFAS Extension. …”
    Get full text
    Article
  7. 1607

    Breast Cancer Series: Hormone Therapy by Karen C. Daily, Martha C. Monroe

    Published 2011-06-01
    “…Women who are at high risk of getting breast cancer and women who have had breast cancer may be prescribed daily oral medications to block the estrogen receptor site or decrease the production of estrogen. …”
    Get full text
    Article
  8. 1608
  9. 1609
  10. 1610
  11. 1611
  12. 1612
  13. 1613
  14. 1614
  15. 1615
  16. 1616
  17. 1617
  18. 1618
  19. 1619

    Efficacy of Group O Washed Red Blood Cell Transfusion on Vital Signs and Hematologic Stability in Trauma Patients With Different Blood Types by Gou XJ, Li LF, He XL, Chen X, Yu AY, Tian WY

    Published 2025-02-01
    “…Xian-Juan Gou,1 Lin-Fei Li,1 Xiao-Li He,1 Xi Chen,2 An-Yong Yu,1 Wei-Yan Tian1 1Department of Emergency, Affiliated Hospital of Zunyi Medical University, Zunyi City, Guizhou Province, 563000, People’s Republic of China; 2School of Nursing, Zunyi Medical University, Zunyi City, Guizhou Province, 563000, People’s Republic of ChinaCorrespondence: Wei-Yan Tian, Department of Emergency, Affiliated Hospital of Zunyi Medical University, Zunyi City, Guizhou Province, 563000, People’s Republic of China, Tel +86 19184321912, Email 907359734@qq.comObjective: To comprehensively assess the impact of emergency transfusion of group O washed red blood cells on the vital signs and hematological parameters of patients with severe trauma and to analyze the differential responses among different blood types, thereby providing valuable evidence for optimizing transfusion strategies.Methods: A retrospective analysis was conducted on the clinical data of patients with severe trauma who underwent emergency transfusion in the hospital’s emergency department from April 2023 to March 2024. …”
    Get full text
    Article
  20. 1620

    Evaluation of Treatment Patterns and Maintenance Dose Titration Among Patients With Crohn’s Disease Initiating Biologics With 3 Years of Follow-Up by Ruizhi Zhao, Zhijie Ding, Parul Gupta, Laurence Gozalo, Robert Bruette, Victor M. Johnson, Keshia Maughn, Yihang Liu, Sumesh Kachroo

    Published 2023-11-01
    “…**Methods:** This retrospective observational study was conducted using the STATinMED RWD Insights all-payer medical and pharmacy data. Adult patients with at least 1 CD medical claim and at least 1 medical/pharmacy claim for a biologic (adalimumab \[ADA\], certolizumab pegol (CZP), infliximab \[IFX\] and its biosimilar products \[IFX-BS\], ustekinumab \[UST\], and vedolizumab \[VDZ\]) between September 2016 and October 2018 were identified. …”
    Get full text
    Article